- The US Food and Drug Administration will allow for the emergency use of
Regeneron‘s COVID-19antibody treatment.
- The antibody treatment was one of the drugs given to President Donald
Trumpafter he was admitted to the hospital with coronavirusin early October.
- Regeneron said it will have enough of the treatment for 80,000 patients by the end of November.
The Food and Drug Administration has allowed for the emergency use of Regeneron’s COVID-19 antibody treatment, a step that will make it more widely available to patients.
FDA granted an emergency authorization for the drug, called REGN-COV2, to be used in people with the coronavirus who are at high risk of developing a severe case of the disease, but not for people who are hospitalized or who need oxygen. REGN-COV2 was one of the treatments
Regeneron said it will have enough of the drug to…